Artis Ventures

ARTIS is proud to have been the first dedicated fund globally to deploy capital wherever data, software, AI, machine learning, and deep learning transform human health and well-being.

At ARTIS we invest in data-driven life sciences companies that solve problems affecting everyday people from across the globe. We care about scalable medical technologies backed by engineering, AI, and strong datasets with broad indications for healthcare and life sciences.

Investing in companies with a TechBio thesis ensures a plethora of indications from a singular biologically engineered approach, opening the door for increased revenue streams, optionality, intellectual property, and flexibility to pivot in times of need.

By combining the best of computer science and the powers of cellular biology, TechBio is the engineering-first approach that enables cures instead of treatments, personalized therapeutics, more efficient drug discovery, and powerful AI-machine-led exploration of biological circuitry.